Core and penumbral nitric oxide synthase activity during cerebral ischemia and reperfusion

Stroke

Volumn 29, Issue 5, 1998, Pages 1037-1047

  Ashwal, Stephen ^a   Tone, Beatriz ^a   Tian, Hui Rou ^a   Cole, Daniel J ^a   Pearce, William J ^b  

^a LOMA LINDA UNIVERSITY   (United States)

^b LOMA LINDA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral ischemia, focal; Cerebrovascular disorders; Ischemia; Nitric oxide; Nitric oxide synthase; Rats

Indexed keywords

FLAVINE ADENINE NUCLEOTIDE; FLAVINE MONONUCLEOTIDE; ISOFLURANE; NITRIC OXIDE SYNTHASE; TETRAHYDROBIOPTERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; CONTROLLED STUDY; ENZYME ACTIVITY; LEFT HEMISPHERE; MALE; MIDDLE CEREBRAL ARTERY OCCLUSION; NONHUMAN; PRIORITY JOURNAL; RAT; REPERFUSION; RIGHT HEMISPHERE; SPONTANEOUSLY HYPERTENSIVE RAT;

EID: 0031959637     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.29.5.1037     Document Type: Article

References (52)

1. Dalkara T, Moskowitz MA. Neurotoxic and neuroprotective roles of nitric oxide in cerebral ischemia. Int Rev Neurobiol. 1997;40:319-336.
2. Nagafuji T, Sugiyama M, Matsui T, Moto A, Naito S. Nitric oxide synthase in cerebral ischemia. Mol Chem Neuropathol. 1995;26:107-157.
3. Dawson DA. Nitric oxide and focal cerebral ischemia: multiplicity of actions and diverse outcomes. Cerebrovasc Brain Metab Rev. 1994;6: 299-324.
4. Iadecola C, Pelligrino, D, Moskowitz MA, Lassen NA. Nitric oxide synthase inhibition and cerebrovascular regulation. J Cereb Blood Flow Metab. 1994;14:175-192.
5. Uemura Y, Kowall NW, Beal MF. Selective sparing of NADPH-diaphorase-somatostatin-neuropeptide Y neurons in ischemic gerbil striatum. Ann Neurol. 1990;27:620-625.
6. Kuppusamy P, Ohnishi ST, Numagami Y, Ohnishi T, Zweier JL. Three-dimensional imaging of nitric oxide production in the rat brain subjected to ischemia-hypoxia. J Cereb Blood Flow Metab. 1995;15:904-913.
7. W-nitro-L-arginine (L-NA) and its methyl ester (L-NAME). Neuropharmacology. 1995;34: 639-649.
8. Bredt DS. Molecular characterization of nitric oxide synthase. In: Vincent SR, ed. Nitric Oxide in the Nervous System. New York, NY: Academic Press, Inc; 1995:1-42.
9. Memezawa H, Minamisawa H, Smith ML, Siesjö BK. Ischemic penumbra in a model of reversible middle cerebral artery occlusion in the rat. Exp Brain Res. 1992;89:67-78.
10. Takagi K, Ginsberg MD, Globus MYT, Dietrich D, Martinez, Kraydieh S, Busto R. Changes in amino acid neurotransmitters and cerebral blood flow in the ischemic penumbra region following middle cerebral artery occlusion in the rat: correlation with histopathology. J Cereb Blood Flow Metab. 1993;13:575-585.
11. Müller TB, Haraldseth O, Unsgård G. Characterization of the microcirculation during ischemia and reperfusion in the penumbra of a rat model of temporary middle cerebral artery occlusion: a laser Doppler flowmetry study. Int J Microcirc. 1994;14:289-295.
12. Brint S, Jacewicz M, Kiessline M, Tanabe J, Pulsinelli W. Focal brain ischemia in the rat: methods for reproducible neocortical infarction using tandem occlusion of the distal middle cerebral and ipsilateral common carotid arteries. J Cereb Blood Flow Metab. 1988;8: 474-485.
13. Cole DJ, Patel PM, Reynolds L, Drummond JC, Marcantonio S. Temporary focal cerebral ischemia in spontaneously hypertensive rats: the effect of ibuprofen on infarct volume. J. Phamacol Exp Ther. 1993;266: 1713-1717.
14. Morikawa E, Huang Z, Moskowitz MA. L-Arginine decreases infarct size caused by middle cerebral arterial occlusion in SHR. Am J Physiol. 1992;263:H1632-H1635.
15. Zhang F, Iadecola C. Reduction of focal cerebral ischemic damage by delayed treatment with nitric oxide donors. J Cereb Blood Flow Metab. 1994;14:574-580.
16. Ashwal S, Cole DJ, Osborne TN, Pearce WJ. Dual effects of L-NAME during transient focal cerebral ischemia in the spontaneously hypertensive rat. Am J Physiol. 1994;267:H276-H284.
17. Folbergrovà J, Memezawa H, Smith ML, Siesjö BK. Focal and perifocal changes in tissue energy state during middle cerebral artery occlusion in normo- and hyperglycemic rats. J Cereb Blood Flow Metab. 1992; 12:25-33.
18. Kader A, Frazzini VI, Solomon RA, Trifiletti RR. Nitric oxide production during focal cerebral ischemia in rats. Stroke. 1993;24: 1709-1716.
19. Yoshida T, Waeber C, Huang Z, Moskowitz MA. Induction of nitric oxide synthase activity in rodent brain following middle cerebral artery occlusion. Neurosci Lett. 1995;194:214-218.
20. Bredt DS, Snyder SH. Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA. 1990;87:682-685.
21. Pearce WJ, Tone B, Ashwal S. Maturation alters cerebral NOS kinetics in the spontaneously hypertensive rat. Am J Physiol. 1997;42:R1-R7.
22. Tobin JR, Martin LD, Breslow MJ, Traystman RJ. Selective anesthetic inhibition of brain nitric oxide synthase. Anesthesiology. 1994;81: 1264-1269.
23. Ashwal S, Cole DJ, Osborne TN, Osborne S, Pearce WJ. L-NAME reduces infarct volume in a filament model of transient middle cerebral artery occlusion in the rat pup. Ped Res. 1995;38:1-5.
24. Tamura A, Graham DI, McCulloch J, Teasdale GM. Focal cerebral ischaemia in the rat, I: description of technique and early neuropathological consequences following middle cerebral artery occlusion. J Cereb Blood Flow Metab. 1981;1:53-60.
25. Hatfield RH, Mendelow AD, Perry RH, Alvarez LM, Modha P. Triphenyltetrazolium chloride (TTC) as a marker for ischaemic changes in rat brain following permanent middle cerebral artery occlusion. Neuropathol Appl Neurobiol. 1991;17:61-67.
26. Bederson J, Pitts L, Germano S, Nishimura M, Davis R, Bartkowski H. Evaluation of 2,3,5-triphenyltelrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke. 1986;17:1304-1308.
27. Bartus RT, Dean RI, Cavanaugh K, Eveleth, D, Carriero DL, Lynch G. Time-related neuronal changes following middle cerebral artery occlusion: implications for therapeutic intervention and the role of calpain. J Cereb Blood Flow Metab. 1995;15:969-979.
28. Swanson RA, Morton MT, Tsao-Wu G, Savalos RA, Davidson C, Sharp FR. A semiautomated method for measuring brain infarct volume. J Cereb Blood Flow Metab. 1990;10:290-293.
29. Hossmann KA. Viability thresholds and the penumbra of focal ischemia. Ann Neurol. 1994;36:557-565.
30. Obrenovitch TP. The ischaemic penumbra: twenty years on. Cerebrovasc Brain Metab Rev. 1995;7:297-323.
31. Siesjö BK. Pathophy siology and treatment of focal cerebral ischemia, part 1: pathophysiology. J Neurosurg. 1992;77:169-184.
32. Siesjö BK. Pathophysiology and treatment of focal cerebral ischemia, part 2: mechanisms of damage and treatment. J Neurosurg. 1992;77: 337-354.
33. Back T, Ginsberg MD, Dietrich WD, Watson BD. Induction of spreading depression in the ischemic hemisphere following middle cerebral artery occlusion: effect on infarct morphology. J Cereb Blood Flow Metab. 1996;16:202-213.
34. Ito U, Kirino T, Kuroiwa T, Klatzo I. Maturation Phenomenon in Cerebral Ischemia, II. Berlin, Germany: Springer-Verlag; 1997:225.
35. Lo EH, Hara H, Rogowska J, Trocha M, Pierce AR, Huang PL, Fishman MC, Wolf GL, Moskowitz MA. Temporal correlation mapping analysis of the hemodynamic penumbra in mutant mice deficient in endothelial nitric oxide synthase gene expression. Stroke. 1996;27:1381-1385.
36. Zhang ZG, Chopp M, Zaloga C, Pollock JS, Forstermann U. Cerebral endothelial nitric oxide synthase expression after focal cerebral ischemia in rats. Stroke. 1993;24:2016-2021.
37. Zhang ZG, Chopp M, Gautam S, Zaloga C, Zhang RL, Schmidt HH, Pollock JS, Forstermann U. Upregulation of neuronal nitric oxide synthase and mRNA, and selective sparing of nitric oxide synthase-containing neurons after focal cerebral ischemia in rat. Brain Res. 1994; 654:85-95.
38. G-Nitro-L-arginine methyl ester reduces necrotic but not apoptotic cell death induced by reversible focal ischemia in rat. Eur J Pharmacol. 1996;310:137-140.
39. Tsuchidate R, He QP, Smith ML, Siesjo BK. Regional cerebral blood flow during and after 2 hours of middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab. 1997;17:1066-1073.
40. Liu Y, Mituska S, Hashizume K, Hosaka T, Nukui H. The sequential change of local cerebral blood flow and local cerebral glucose metabolism after focal cerebral ischaemia and reperfusion in rat and the effect of MK-801 on local cerebral glucose metabolism. Acta Neurochir (Wien). 1997;139:770-779.
41. Zaharchuk G, Hara H, Huang PL, Fishman MC, Moskowitz MA, Jenkins BG, Rosen BR. Neuronal nitric oxide synthase mutant mice show smaller infarcts and attenuated apparent diffusion coefficient changes in the peri-infarct zone during focal cerebral ischemia. Magn Reson Med. 1997; 37:170-175.
42. Iadecola C, Xu X, Zhang F, el Fakahany EE, Ross ME. Marked induction of calcium-independent nitric oxide synthase activity after focal cerebral ischemia. J Cereb Blood Flow Metab. 1995;15:52-59.
43. Sessa WC, Barber CM, Lynch KR. Mutation of N-myristoylation site converts endothelial cell nitric oxide synthase from a membrane to a cytosolic protein. Circ Res. 1993;72:921-924.
44. Hecker M, Mulsch A, Busse R. Subcellular localization and characterization of neuronal nitric oxide synthase. J Neurochem. 1994;62:1524-1529.
45. Bredt DS, Glatt CE, Hwang PM, Fotuhi M, Dawson TM, Snyder SH. Nitric oxide synthase protein and mRNA are discretely localized in neuronal populations of the mammalian CNS together with NADPH diaphorase. Neuron. 1991;7:615-624.
46. Förstermann U, Gorsky LD, Pollock JS, Schmidt HH, Heller M, Murad F. Regional distribution of EDRF/NO-synthesizing enzyme(s) in rat brain. Biochem Biophys Res Commun. 1990;168:727-732.
47. Barjavel MJ, Bhargava HN. Nitric oxide synthase activity in brain regions and spinal cord of mice and rats: kinetic analysis. Pharmacology. 1995; 50:168-174.
48. Scremin OU. Cerebral vascular system. In: Paxinos G, ed. The Rat Nervous System. 2nd ed. New York, NY: Academic Press. Inc; 1995:3-35.
49. Mulhonen M, Heisted DD, Faraci FM, Loftus CM. Augmentation of blood flow through cerebral collaterals by inhibition of nitric oxide synthase. J Cereb Blood Flow Metab. 1994;14:704-714.
50. Watkins LD. Nitric oxide and cerebral blood flow: an update. Cerebrovasc Brain Metab Rev. 1995;7:324-337.
51. Terasako K, Nakamura K, Miyawaki I, Toda H, Kakuyama M, Mori K. Inhibitory effects of anesthetics on cyclic guanosine monophosphate (cGMP) accumulation in rat cerebellar slices. Anesth Analg. 1994;79: 921-926.
52. Rengasamy A, Ravichandran LV, Reikersdorfer CG, Johns RA. Inhalational anesthetics do not alter nitric oxide synthase activity. J Pharmacol Exp Ther. 1995;273:599-604.